[1] |
WANG Xiu, JI Qilin, PEI Wenjun, ZENG Ying.
3-bromopyruvate cholesterol ester enhances the sensitivity of breast cancer cells to tamoxifen
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1093-1100.
|
[2] |
SUN Ying, YU Qin.
Research progress on the imbalance of coagulation and fibrinolysis system and the pathogenesis and treatment of idiopathic pulmonary interstitial fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 689-695.
|
[3] |
LIU Peng, ZHAO Hailing, SHEN Zhengri, WANG Chen, WANG Yun, QIU Xinping, LI Ping.
Tangshen formula promotes cellular cholesterol efflux in HG-induced mTECs by suppression of TGF-β1/Smad3 pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(1): 1-9.
|
[4] |
TUO Qin-hui, YUAN Hao-yu, GUO Yan, YU Wei-xia , LIAO Duan-fang.
Ezetimibe inhibiting intracellular lipid accumulation through caveolin-1 in rat vascular smooth muscle cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(5): 492-495.
|
[5] |
HUO Yong-jia.
Effects of fluvastatin on exercise-induced myocardial ischemia in patients with stable exertional angina pectoris and hypercholesterolemia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(2): 200-203.
|
[6] |
XIE Xiang-rong, WANG Ming, ZHANG Hou-jun, SHAN Shou-jie, LIU Zhi-zhong, CHEN Shao-liang.
Effects of atorvastatin on recession of coronary plaque and its components
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(4): 438-442.
|
[7] |
QIN Yan-wen, YE Ping, WANG Lu-ya, YANG Ya.
Primary prevention effect of atorvastatin on myocardial hypertrophy in ApoE-deficient (ApoE-/-) mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(1): 48-51.
|
[8] |
ZHANG Xin-bo, WANG Lv-ya.
Review of new cholesterol absorption inhibitor ezetimibe
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(3): 258-261.
|
[9] |
YAN Li-ping, CHEN Shun-hong, CHEN Wei-min, CHEN Shi-lin, MA Xiao-jun, XU Hong-xi.
Regulatory effect of puerarin on lipid profile in hypercholesterolemic rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(5): 574-577.
|
[10] |
ZHU Ying, YAN Xiao-wei, CHEN Lian-feng, WANG Jing-feng, FANG Quan.
Effect of atorvastatin on intracellular cholesterol content and efflux of macrophages separated from diabetic hamster
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(12): 1355-1359.
|
[11] |
LI Qin-Kai, YIN Wei-Dong.
Progress on the drugs for regulating high-density lipoprotein
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(8): 841-844.
|
[12] |
LI Jing-Rong, XIONG Shu-Dao, LI Yu-Guang, ZHANG Yuan-Chun.
Effects of amlodipine on expression of nitric oxide synthase in myocardial ischemia reperfusion model in hypercholesterolemia rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(8): 901-905.
|
[13] |
HUO Yong-Jia, CHENG Ying, CHENG Li.
Clinical evaluation of efficacy of simvastatin on exercise-induced myocardial ischemia in patients with stable exertional angina pectoris and hypercholesterolemia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(8): 929-931.
|
[14] |
WANG Qian, WANG Hai.
Effects of vascular novel compoundPivanampeta on modulating function of endothelium against atherosclerosis1
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003, 8(4): 374-380.
|
[15] |
DUAN Yan-Nan, LIU Yuan-Bo.
Cardiovascular pharmacodynamics of the Riyuedan capsule in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2002, 7(1): 41-42.
|